Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04254575 · ClinicalTrials.gov registry record
Understanding Daily Changes in BDD Risk Using Smartphones
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 87
- Enrollment target
NCT04254575: Completed study, sponsored by Massachusetts General Hospital.
NCT04254575 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04254575 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
Body dysmorphic disorder (BDD) is associated with high risk for suicide attempts (22-28%) and substance use disorders (49%), underscoring the importance of accurate, real-time risk detection in BDD. This study aims to use smartphone-based digital phenotyping to develop and validate unobtrusive, time-sensitive, and ecologically valid measures of key risk factors for suicide and substance misuse in BDD: negative affect states. As next steps, this research can be extended to detect risk transdiagnostically, with the goal of enabling just-in-time interventions to target suicide and substance misuse across psychiatric illnesses.
Interventions
- OTHER None, observational study only (no interventions)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2020-07-15 |
| Est. Completion | 2023-04-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04254575
The ClinicalTrials.gov registry entry for NCT04254575 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which None, observational study only (no interventions) is the first listed.
NCT04254575 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04254575 about?
NCT04254575 is a clinical study titled "Understanding Daily Changes in BDD Risk Using Smartphones". Body dysmorphic disorder (BDD) is associated with high risk for suicide attempts (22-28%) and substance use disorders (49%), underscoring the importance of accurate, real-time risk detection in BDD. This study aims to use smartphone-based digital phenotyping to develop and validate unobtrusive, time...
What is the current status of trial NCT04254575?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2020-07-15. Estimated completion is 2023-04-28.
What interventions are being tested in trial NCT04254575?
The interventions under investigation include: None, observational study only (no interventions) (OTHER).
Who is sponsoring clinical trial NCT04254575?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.